In Vitro Diagnostics (IVD) Market to Reach US$ 10 Billion by 2021 In Vitro Diagnostics Market China Report 2021 | Page 3

In Vitro Diagnostics Industry: China Market Size, Share, Trends, Volume and
2021 Forecasts Report
“China In Vitro Diagnostics(IVD) – Opportunity Assessment, Competitive Landscape and Market Forecasts
to 2021” has been analyzed from 10 viewpoints:
Market and Forecast (2010 – 2021)
Segment Wise Market and Forecast (2010 – 2021)
Company Wise IVD Sales and Forecast (2010 – 2021)
Regulation and its Latest Development
Future Prospects in Attractive In Vitro Diagnostics Segments
Regional Trends and Opportunities
Main Participants/Contributors
Major IVD Product Companies Outlook
Major Private Clinical Labs and Diagnostic Services Companies Outlook
Market Growth Drivers and Challenges
China IVD Market: Companies wise Outlook:
Roche is the leading company with more than XX% market share in the China IVD market and is expected to
hold its strong position in the market. Sysmex Corporation and Abbott Laboratories are the other top two
players in the China IVD market. Mindray and Shanghai Kehua Bioengineering(KHB) are another major
participant in this market with a good hold in clinical chemistry, immunoassay and molecular testing
segments providing varieties of reagents nationwide and semi–auto and automatic biochemistry analyzers
to low and mid–end market users.
Purchase a Copy of This Report at
http://www.marketreportsonline.com/contacts/purchase.php?name=496440